The Peptide Company
$0.00 0

Cart

No products in the cart.

Continue shopping

Description

FOXO4-DRI – 2mg

This is not for human consumption.  For research purposes only.

CAS Number: 2460055-10-9

FOXO4-DRI is a modified peptide sequence designed for research involving senescent cell signaling and FOXO4-p53 pathway interactions. In preclinical models, FOXO4-DRI has been explored for its potential role in selectively targeting dysfunctional senescent cells through apoptosis-related mechanisms.

Current scientific interest surrounding FOXO4-DRI centers on:

  • Cellular senescence research
  • Longevity and aging pathway studies
  • p53 signaling interactions
  • Senolytic compound investigations
  • Tissue regeneration and recovery models

Researchers have investigated FOXO4-DRI in relation to age-associated cellular accumulation and its downstream effects on tissue function and inflammatory signaling.

Product Specifications

  • Compound: FOXO4-DRI
  • Quantity: 2mg
  • Format: Lyophilized research material
  • Intended Use: Research purposes only
  • Not for human consumption

Reviews

There are no reviews yet.

Be the first to review “FOX04 DRI – 2MG”

Your email address will not be published. Required fields are marked *